CCP110 protein, human: Clinical Trials

5 trials of CCP110 protein, human, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting. 5 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 3, Recruiting 2

Follow CCP110 protein, human: new trials by email Literature Review of CCP110 protein, human trials Research Report on CCP110 protein, human

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea
STANDART CARE, STANDART CARE & FAN THERAPY - Acute Coronary Syndromes, Ticagrelor
Not applicableRecruitingAcibadem University1102025-03-152025-12-08
Skin Surface and Intradermal Temperature Responses to Heat Stress
Control, Fan, Fan and Water Spray - Hyperthermia
Not applicableCompletedUniversity of Texas Southwestern Medical Center272024-10-012026-08-14
Heat Waves and the Elderly - Cooling Modalities
Water Spray, Fan, Water Spray and Fan - Aging, Hyperthermia
Not applicableRecruitingUniversity of Texas Southwestern Medical Center1002023-02-212026-09-08
Exercise in Burn Survivors: Cooling Modalities
Control (no cooling modalities), Water Spray Only, Fan Only - Burn Injury
Not applicableCompletedUniversity of Texas Southwestern Medical Center702021-01-152026-10-30
Identifying Strategies to Alleviate Cardiovascular Stress in Coronary Patients During Heatwaves
No intervention, Fan, Skin Wetting - Coronary Artery Disease
Not applicableCompletedMontreal Heart Institute272019-02-182023-08-01

Conditions studied

Hyperthermia (2)  ·  Acute Coronary Syndrome (1)  ·  Burns (1)  ·  Coronary Artery Disease (1)  ·  Dyspnea (1)

Sponsors

University of Texas Southwestern Medical Center (3)  ·  Acibadem University (1)  ·  Montreal Heart Institute (1)

Countries

United States (3)  ·  Canada (1)  ·  Turkey (Türkiye) (1)

Top investigators

Craig Crandall, Ph.D. (1)

NIH funding

R01GM068865 (1)